Letter. The cheaper drug, bevacizumab, should be referred to NICE
Letter. The cheaper drug, bevacizumab, should be referred to NICE
eye, ranibizumab
381-382
Raftery, J.P.
27c2661d-6c4f-448a-bf36-9a89ec72bd6b
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
2007
Raftery, J.P.
27c2661d-6c4f-448a-bf36-9a89ec72bd6b
Lotery, A.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Raftery, J.P. and Lotery, A.
(2007)
Letter. The cheaper drug, bevacizumab, should be referred to NICE.
BMJ, 334 (381), .
(doi:10.1136/bmj.39128.708565.3A).
This record has no associated files available for download.
More information
Published date: 2007
Keywords:
eye, ranibizumab
Identifiers
Local EPrints ID: 62553
URI: http://eprints.soton.ac.uk/id/eprint/62553
ISSN: 0959-8138
PURE UUID: c0d83ba7-aaeb-440a-b9c9-5e846e21a389
Catalogue record
Date deposited: 11 Sep 2008
Last modified: 16 Mar 2024 03:31
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics